Combination therapy with broadly neutralizing antibodies, antiretroviral therapy and CCR5 blockade limits viral reservoir seeding in infant macaque model of HIV - Nature

What the report says

A combined therapy using broadly neutralizing antibodies that target the HIV envelope protein, the CCR5-blocking antibody leronlimab and antiretroviral therapy limits seeding of the viral reservoir in an infant macaque model of HIV at 72 h post-infection.